GIPR signaling opens brain’s gate for GLP-1 weight-loss therapy

A new study uncovers how GIPR signaling in brain cells helps GLP-1 weight-loss drugs bypass the blood-brain barrier and amplify their appetite-suppressing effects, offering a mechanistic explanation for the clinical power of…